Cosmetic cross-reference

Acetaldehyde

CAS 75-07-0

Acetaldehyde (CAS 75-07-0) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

1

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

4

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Acetaldehyde

CAS Number

75-07-0

UNII

GO1N1ZPR3B

InChIKey

IKHGUXGNUITLKF-UHFFFAOYSA-N

ChEMBL ID

CHEMBL170365

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Potency	41429.93333333333 nM	3	-

SOURCE IUPHAR/BPS 3 interactions

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

Target	Action	Affinity	PubMed
TRPA1 TRPA1	Activation	4.1 pEC50	17970723
TRPA1 Trpa1	Activation	2.9 pEC50	17970723
TRPV6 TRPV6	Activation	6.699999809265137 pEC50	35705057

SOURCE PharmGKB 9 phenotype rows

Pharmacogenomics

Drug-gene phenotype annotations and evidence levels from PharmGKB-mapped rows.

ADH1A (PA24570) rs1229976

Genotype CT is associated with increased concentrations of acetaldehyde in healthy individuals as compared to genotype TT.

Evidence: -; PMID 31002879

PGM1 (PA33242) rs4643

Genotype CC is associated with increased concentrations of acetaldehyde in healthy individuals as compared to genotypes AA + AC.

Evidence: -; PMID 31002879

ADH1B (PA24571) rs1229984

Genotype CT is associated with increased concentrations of acetaldehyde in healthy individuals as compared to genotypes CC + TT.

Evidence: -; PMID 31002879

ALDH2 (PA24696) rs671

Genotype AG is associated with increased concentrations of acetaldehyde in healthy individuals as compared to genotype GG.

Evidence: -; PMID 31002879

SRPRB (PA128394701) rs17376019

Genotype CT is not associated with concentrations of acetaldehyde in healthy individuals as compared to genotype CC.

Evidence: -; PMID 31002879

ADH1A rs1229976

-

Evidence: 3; PMID 1

ALDH2 rs671

-

Evidence: 3; PMID 1

ADH1B rs1229984

-

Evidence: 3; PMID 1

PGM1 rs4643

-

Evidence: 3; PMID 1

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
ACETALDEHYDE	1311137	SU	MTHSPL
acetaldehyde	1311137	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Acetaldehyde used for in pharmaceutical contexts?

Acetaldehyde (CAS 75-07-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Acetaldehyde?

No adverse-event association or SIDER side-effect rows are rendered for Acetaldehyde in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Acetaldehyde also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for ACETALDEHYDE with EU status "restricted".

What clinical phase is Acetaldehyde in?

No phase 1-4 clinical development badge is rendered for Acetaldehyde because the matched compound identifier rows do not contain a max-phase value.